Similarly, compared to patients with prostatic inflammation or BPH, prostate cancer patients exhibited elevated peripheral PTX3 levels, which increased over time, suggesting a tumor-promoting role of PTX3 during prostatic inflammation or BPH (75, 76). Here, PTX3 is linked to prostate carcinoma.